Gene · 22861
Papers3,738
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,738
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of inflammasome components in patients with heart failure using oral nutritional supplements: investigating the molecular mechanisms beyond the clinical benefit. | Eur J Nutr | 2026 | 41632188 | PubTator, text mining | PubMed |
| Abstracts from the Annual Pathology Conference of Victor Babeș Institute. | BMC Proc | 2026 | 41629918 | PubTator, text mining | PubMed |
| Neuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting. | Ann Med | 2026 | 41601146 | PubTator, text mining | PubMed |
| Evaluation of ASC as a therapeutic target for Alzheimer's disease. | Alzheimers Dement | 2026 | 41582303 | PubTator, text mining | PubMed |
| RSV temporally reprograms apoptosis and pyroptosis to balance immune evasion and replication. | Sci Adv | 2026 | 41576161 | PubTator, text mining | PubMed |
| Pyroptosis in Peripheral Neuropathy: From Molecular Mechanisms to Therapeutic Targeting. | CNS Neurosci Ther | 2026 | 41574659 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review. | J Neurochem | 2026 | 41572495 | PubTator, text mining | PubMed |
| Engineered Akkermansia muciniphila vesicles for targeted pyroptosis and trained immunity to enhance immunotherapy in hepatocellular carcinoma. | Cell Rep Med | 2026 | 41564859 | PubTator, text mining | PubMed |
| Bacterial synthesis of personalized biomimetic biological cornea. | Bioact Mater | 2026 | 41551761 | PubTator, text mining | PubMed |
| COVID-19 immunopathological features for the prediction and prevention of future emerging respiratory viral infections. | Comput Struct Biotechnol J | 2026 | 41551039 | PubTator, text mining | PubMed |
| Autoinflammatory syndrome associated with a variant of the NLRP1 gene (NAIAD): description of a pediatric case treated with canakinumab. | Med Clin (Barc) | 2026 | 41539075 | PubTator, text mining | PubMed |
| Redefining Shiga toxin-induced human cell death as NLRP1- and gasdermin E-mediated pyroptosis. | Proc Natl Acad Sci U S A | 2026 | 41533439 | PubTator, text mining | PubMed |
| TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome. | EMBO Mol Med | 2026 | 41514124 | PubTator, text mining | PubMed |
| Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment. | J Clin Invest | 2026 | 41468163 | PubTator, text mining | PubMed |
| The Role of NLRP1, AIM2 and MEFV Inflammasomes in the High-Intensity Interval Training of Individuals With Obesity. | Immunology | 2026 | 41422827 | PubTator, text mining | PubMed |
| NLRP1 as a Novel Pyroptosis Biomarker in Irreversible Pulpitis: A Laboratory Investigation and Animal Model Study. | Int Endod J | 2026 | 41400095 | PubTator, text mining | PubMed |
| IFNγ priming enables NLRP3 inflammasome activation in human keratinocytes in vitro. | J Invest Dermatol | 2026 | 41389956 | PubTator, text mining | PubMed |
| Scorpion polypeptide BmK IT2 alleviates epileptic seizures and neuronal pyroptosis by regulating sodium channel Nav1.6. | J Ethnopharmacol | 2026 | 41197923 | PubTator, text mining | PubMed |
| Phenotypes of patients with more than one autoinflammatory disease-associated gene variant: overlapping and mixed autoinflammatory disorders. | Rheumatology (Oxford) | 2026 | 41191928 | PubTator, text mining | PubMed |
| Identification of ATG4B and NLRP1 as M1 Macrophage-Activating-Related Plasma Proteins in Systemic Lupus Erythematosus via Multi-Omics Approaches. | Int Arch Allergy Immunol | 2026 | 40892678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22861/papers?page=5